JPRN-UMIN000025372已完成未知
Comparison of antihypertensive medical care using telemedicine vs. conventional therapy - Telemedicine comparison trial for hypertension
Tokyo Women's Medical University0 个研究点目标入组 450 人开始时间: 2016年12月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 450
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Those who do not own a smartphone compatible with the telemedicine platform 2) Past history of coronary diseases 3) Those with diabetes mellitus, chronic kidney disease, history of stroke, or peripheral artery disease 4) Those classified as Category III according to the cardiovascular risk chart by Japan Atherosclerosis Society 5) Pregnant women and those with high possibility of becoming pregnant 6) Secondary hypertension, excluding idiopathic hyperaldosteronism and primary aldosteronism after adrenalectomy 7) Those judged by research administrator to be inappropriate for the study
研究者
相似试验
已完成
4 期
Comparing anti-hypertensive combination therapy of fixed dose losartan and hydrochlorothiazide(HCTZ) versus angiotensin receptor blocker(ARB) and calcium channel blocker(CCB) on hypertensive patients whose blood pressures don't lower enough,effect and influence of metabolic system trial.HypertensionJPRN-UMIN000001692Hypertension and Metabolism Study group in East Saitama300
进行中（未招募）
不适用
Application of physiotherapy to reduce pressurehypertensionRBR-5jt8k2Faculdade Independente do Nordeste - FAINOR
已完成
不适用
Assessment of the Effect of Anti-hypertensive Medication on Central Blood Pressure Using Home BP deviceHypertensionJPRN-UMIN000005655The Second Department of Internal Medicine Tokyo Medical University100
已完成
不适用
Comparison of the effect of anti-hypertensive treatment with verapamil and amlodipine on the coronary vasodilator reserve and the transmural distribution of myocardial blood flow in hypertensive patients with left ventricular hypertrophyCirculatory SystemHypertensionISRCTN35563487Abbott (Germany)50
已完成
不适用
Evaluation for drug combination of antihypertensive agent and lipid-lowering agent in patients with hypertension and dyslipidemiaHypertension and dyslipidemiaJPRN-UMIN000008539Saitama Medical Center, Saitama Medical University30